TL
Tiziana Life Sciences Ltd
TLSA · NASDAQ
$0.98 -1.38% (-$0.01)
1M -3.30%
Market Cap $62.1M
P/E Ratio -
Div. Yield -
ROE 490.09%
Bulios Fair Price
$0.71
27.3% downside
Trenutna cena
$0.98
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TLSA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 1,195.13x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 86.15%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 4,189.76%
ROE 490.09%
ROA 160.34%
Debt
5 /100
High Debt/Equity 8.77x
Current ratio 0.76x
Int. coverage -1,182.44x
Stability
42 /100
Moderate Beta 0.46x
EPS volatility 47.65%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TLSA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ivor R. Elrifi
Employees
10
Headquarters
London
Prihajajoči dogodki
18 SEP.
Earnings
Upcoming earnings report